Dr. Hofherr joined Fabric Genomics in September of 2022, bringing clinical expertise and over a decade of experience in molecular diagnostics. At Fabric, Dr. Hofherr leads the strategy around the development of the Fabric Enterprise Platform as well as scientific and clinical utility of Fabrics offerings. Prior to joining Fabric, Dr. Hofherr, served as Chief Scientific Officer of GeneDx. During his tenure, he led the shift to scalable exome and genome testing including rapid offerings for both, setting the path for the testing firm to become the leader in large scale clinical genomics. His background also includes building the Molecular Diagnostics program at Childrens National Hospital in Washington, DC where he introduced a firstinclass Personalized Sequencing Panels. Dr. Hofherr completed his clinical training in Molecular and Biochemical Genetics from the Mayo Clinic. He received his PhD from Baylor College of Medicine in Molecular and Human Genetics.
Clinical Dx Showcase:
Session Abstract – PMWC 2024 Silicon Valley
The PMWC 2024 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Nerodegenerative